FULL EVENT GUIDE

Get Your Copy of the Full Event Guide Now:

Download the comprehensive event guide to view the complete agenda, the speaker line-up, networking opportunities and much more!

What Can You Expect?

  • 70+ Hippo pathway experts and drug developers
  • 20+ expert speakers
  • 5+ hours of built-in networking time
  • 4 interactive and deep-diving panels
Screenshot 2024-09-27 145220

*Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Catch the Latest Clinical Data from Leading Hippo Companies:

Journey of VT3989: Clinical Insights & Overcoming Challenges

Neelesh Sharma, Chief Medical Officer, Vivace Therapeutics

Neelesh Sharma, Hippo Pathway Targeted Drug Development Summit

Presenting a Novel Pan TEAD Inhibitor to Treat Hippo Pathway Dysregulated Tumors

Michelle Chen, Chief Business Officer, Insilico Medicine

Michelle Chen, Hippo Pathway Targeted Drug Development Summit

Discovery & Development of a Novel Covalent TEAD Inhibitor with Exceptional Anti-Cancer Activity & Druggability

Shirley Guo, Director of Biology, BridGene Biosciences

Shirley Guo, Hippo Pathway Targeted Drug Development Summit